Recognition places Foothill Regional among the top 5% in the nation for patient safety TUSTIN, Calif., March 10, 2026 /PRNewswire/ -- Foothill Regional Medical Center, part of Astrana Health, Inc. (NASDAQ:ASTH), has been recognized as a 2026 Patient Safety Excellence Award™ recipient by Healthgrades, the nation's leading resource Americans use when searching for a hospital or doctor. Foothill Regional has received the Patient Safety Excellence Award™ four consecutive years (2023-2026). In addition to this patient safety recognition, Foothill Regional has earned several distingui

ALHAMBRA, Calif., March 3, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that leadership is participating in the following upcoming investor conferences: The TD Cowen 45th Annual Health Care Conference, being held in Boston on Wednesday, March 4, 2026, including a fireside chat at 9:10am ET.The Jefferies Value-Based Healthca

Company to Host Conference Call on Monday, March 2, 2026, at 5:30 a.m. PT/8:30 a.m. ETReports total revenue for the year ended of $3,181.8 million, up 56% year-over-year, and at the higher end of guidanceReports adjusted EBITDA for the year ended of $205.4 million and free cash flow(1) of $104.5 millionALHAMBRA, Calif., March 2, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading physician-centric, technology-powered, risk-bearing healthcare management company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial result

ALHAMBRA, Calif., Jan. 26, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and year ended December 31, 2025, before the open of the stock market on Monday, March 2, 2026. The Company will discuss those results on a conference call at 5:30 a.m. PT/8:30 a.m. ET that same day.

ALHAMBRA, Calif., Jan. 6, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that leadership is participating in the J.P. Morgan 2026 Healthcare Conference, being held in San Francisco, on Monday, January 12, 2026, including a presentation at 5:15pm PT. The webcast link and related presentation materials will be available in the "IR Calendar" section of the Company's website: https://ir.astranahealth.com/news-events/ir-calendar.

Company to Host Conference Call on Thursday, November 6, 2025, at 2:30 p.m. PT/5:30 p.m. ET Reports total revenue of $956.0 million, up 100% year-over-year, and at the higher end of guidanceReports adjusted EBITDA of $68.5 million, at the higher end of guidanceCloses Prospect Health acquisition where standalone third quarter performance exceeded expectationsContinuing to control medical costs well; reiterating full-year trend expectationsUpdates full-year 2025 guidance to account for full-risk contract delays unrelated to core performanceALHAMBRA, Calif., Nov. 6, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (

ALHAMBRA, Calif., Oct. 15, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the third quarter ended September 30, 2025, after the close of the stock market on Thursday, November 6, 2025. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

ALHAMBRA, Calif., Sept. 2, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that company management is participating at the Wells Fargo Healthcare Conference from Wednesday, September 3rd to Thursday, September 4th, the Morgan Stanley Global Healthcare Conference on Tuesday, September 9th with a broadcasted Fireside Chat from 5:35PM – 6:10PM ET, as well as the Baird Healthcare Conference on Wednesday, September 10th.

Company to Host Conference Call on Thursday, August 7, 2025, at 2:30 p.m. PT/5:30 p.m. ET Reports total revenue of $654.8 million and adjusted EBITDA of $48.1 million, both at the higher end of guidanceContinues to manage medical cost trends effectively, with trend within expectations across all lines of businessReiterates full-year 2025 guidance which is inclusive of the now-closed Prospect Health acquisitionALHAMBRA, Calif., Aug. 7, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-qual

ALHAMBRA, Calif., July 22, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the second quarter ended June 30, 2025, after the close of the stock market on Thursday, August 7, 2025. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

Needham initiated coverage of Astrana Health with a rating of Buy and set a new price target of $28.00

Barclays initiated coverage of Astrana Health with a rating of Equal Weight and set a new price target of $36.00

TD Cowen initiated coverage of Astrana Health with a rating of Buy and set a new price target of $66.00

KeyBanc Capital Markets initiated coverage of Astrana Health with a rating of Sector Weight

Truist upgraded Astrana Health from Hold to Buy and set a new price target of $50.00 from $44.00 previously

Robert W. Baird initiated coverage of Astrana Health with a rating of Outperform and set a new price target of $54.00

4 - Astrana Health, Inc. (0001083446) (Issuer)

4 - Astrana Health, Inc. (0001083446) (Issuer)

4 - Astrana Health, Inc. (0001083446) (Issuer)

4 - Astrana Health, Inc. (0001083446) (Issuer)

4 - Astrana Health, Inc. (0001083446) (Issuer)

4 - Astrana Health, Inc. (0001083446) (Issuer)

4 - Astrana Health, Inc. (0001083446) (Issuer)

4 - Astrana Health, Inc. (0001083446) (Issuer)

4 - Astrana Health, Inc. (0001083446) (Issuer)

4 - Astrana Health, Inc. (0001083446) (Issuer)

10-K - Astrana Health, Inc. (0001083446) (Filer)

8-K - Astrana Health, Inc. (0001083446) (Filer)

NT 10-K - Astrana Health, Inc. (0001083446) (Filer)

8-K - Astrana Health, Inc. (0001083446) (Filer)

SCHEDULE 13G/A - Astrana Health, Inc. (0001083446) (Subject)

8-K - Astrana Health, Inc. (0001083446) (Filer)

D - Astrana Health, Inc. (0001083446) (Filer)

10-Q - Astrana Health, Inc. (0001083446) (Filer)

8-K - Astrana Health, Inc. (0001083446) (Filer)

8-K/A - Astrana Health, Inc. (0001083446) (Filer)

Company to Host Conference Call on Monday, March 2, 2026, at 5:30 a.m. PT/8:30 a.m. ETReports total revenue for the year ended of $3,181.8 million, up 56% year-over-year, and at the higher end of guidanceReports adjusted EBITDA for the year ended of $205.4 million and free cash flow(1) of $104.5 millionALHAMBRA, Calif., March 2, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading physician-centric, technology-powered, risk-bearing healthcare management company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial result

ALHAMBRA, Calif., Jan. 26, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and year ended December 31, 2025, before the open of the stock market on Monday, March 2, 2026. The Company will discuss those results on a conference call at 5:30 a.m. PT/8:30 a.m. ET that same day.

Company to Host Conference Call on Thursday, November 6, 2025, at 2:30 p.m. PT/5:30 p.m. ET Reports total revenue of $956.0 million, up 100% year-over-year, and at the higher end of guidanceReports adjusted EBITDA of $68.5 million, at the higher end of guidanceCloses Prospect Health acquisition where standalone third quarter performance exceeded expectationsContinuing to control medical costs well; reiterating full-year trend expectationsUpdates full-year 2025 guidance to account for full-risk contract delays unrelated to core performanceALHAMBRA, Calif., Nov. 6, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (

ALHAMBRA, Calif., Oct. 15, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the third quarter ended September 30, 2025, after the close of the stock market on Thursday, November 6, 2025. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

Company to Host Conference Call on Thursday, August 7, 2025, at 2:30 p.m. PT/5:30 p.m. ET Reports total revenue of $654.8 million and adjusted EBITDA of $48.1 million, both at the higher end of guidanceContinues to manage medical cost trends effectively, with trend within expectations across all lines of businessReiterates full-year 2025 guidance which is inclusive of the now-closed Prospect Health acquisitionALHAMBRA, Calif., Aug. 7, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-qual

ALHAMBRA, Calif., July 22, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the second quarter ended June 30, 2025, after the close of the stock market on Thursday, August 7, 2025. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

Company to Host Conference Call on Thursday, May 8, 2025, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., May 8, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the first quarter ended March 31, 2025. "Astrana's strong start to the year reflects the continued momentum behind our mis

ALHAMBRA, Calif., April 15, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the first quarter ended March 31, 2025, after the close of the stock market on Thursday, May 8, 2025. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

Company to Host Conference Call on Thursday, February 27, 2025, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Feb. 27, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the fourth quarter and year ended December 31, 2024. "Astrana Health's strong performance in 2024 highlights the s

ALHAMBRA, Calif., Feb. 17, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2024, after the close of the stock market on Thursday, February 27, 2025. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.